Current Report Filing (8-k)
May 09 2019 - 4:38PM
Edgar (US Regulatory)
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
8-K
|
|
CURRENT
REPORT
|
Pursuant
to Section 13 or 15(d) of the
Securities
Exchange Act of 1934
|
|
Date
of Report (Date of earliest event reported):
May 9, 2019
|
|
SPHERIX
INCORPORATED
|
(Exact
name of registrant as specified in its charter)
|
Delaware
|
000-05576
|
52-0849320
|
(State
or other jurisdiction
of
incorporation)
|
(Commission
File
Number)
|
(I.R.S.
Employer
Identification
No.)
|
|
|
|
One
Rockefeller Plaza, 11
th
Floor, New York, NY
|
10020
|
(Address
of principal executive offices)
|
(Zip
Code)
|
|
Registrant’s
telephone number, including area code:
(212) 745-1374
|
|
Check the
appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant
under any of the following provisions:
|
|
☐
|
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
|
☐
|
Soliciting material
pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
|
|
☐
|
Pre-commencement communications
pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
|
|
☐
|
Pre-commencement communications
pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13a-4(c))
|
Indicate
by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405
of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging
growth company ☐
If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for
complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Securities
registered pursuant to Section 12(b) of the Act:
Title
of each class
|
Trading
Symbol(s)
|
Name
of each exchange on which registered
|
Common
Stock, $0.0001 par value
|
SPEX
|
The
Nasdaq Capital Market LLC
|
|
Item
3.03
|
Material
Modification to Rights of Security Holders.
|
On
May 9, 2019, Spherix Incorporated, a Delaware corporation (the “
Company
,” “
our
,” “
we
”
or “
us
”) filed a Certificate of Amendment to the Company’s Amended and Restated Certificate of Incorporation
with the Secretary of State of Delaware on May 9, 2019 (the “
Certificate of Amendment
”) to effectuate a reverse
stock split of the Company’s issued and outstanding shares of common stock at a ratio of 4.25-for-one (the “
Reverse
Stock Split
”). The Reverse Stock Split, which was approved by the Company’s board of directors under authority
granted by the Company’s stockholders at the Company’s 2019 Annual Meeting of Stockholders held on April 15, 2019,
will become effective at 12:01 a.m., Eastern Standard Time, on May 10, 2019 (the “
Effective Date
”). A copy
of the Certificate of Amendment is attached hereto as Exhibit 3.1 and is incorporated herein by reference.
Upon
the effectiveness of the Reverse Stock Split, the Company’s issued and outstanding shares of common stock will decrease
from approximately 8,542,530 shares to approximately 2,010,074 shares of common stock, all with a par value of $0.0001 per share.
Fractional shares resulting from the Reverse Stock Split will be rounded up to the next whole number. The amount of authorized
shares of common stock (100,000,000 shares) will not be affected by the Reverse Stock Split.
The
Company has effected the Reverse Stock Split to satisfy the $1.00 minimum bid price requirement, as set forth in Listing Rule
5550(a)(2) (the “
Rule
”), for continued listing on The NASDAQ Capital Market (“
Nasdaq
”).
As previously disclosed, on November 27, 2018, the Staff of the Listing Qualifications Department of The Nasdaq Stock Market LLC
(the “
Nasdaq Staff
”) notified the Company that it did not comply with the requirements of the Rule, and the
Company was granted 180 calendar days, through May 28, 2019, to regain compliance.
The
Reverse Stock Split becomes effective with Nasdaq and the Company’s common stock will begin trading on a split-adjusted
basis at the open of business on May 10, 2019. In connection with the Reverse Stock Split, the CUSIP number for the common
stock will change to 84842R502.
Item
5.03
|
Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year.
|
The
information set forth in Item 3.03 of this Current Report on Form 8-K is hereby incorporated by reference into this Item 5.03.
|
Item
9.01
|
Financial
Statements and Exhibits.
|
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf
by the undersigned hereunto duly authorized.
Dated:
May 9, 2019
|
SPHERIX INCORPORATED
|
|
|
|
|
By:
|
/s/ Anthony Hayes
|
|
Name: Anthony Hayes
|
|
Title: Chief Executive Officer
|
Alkido Pharma (NASDAQ:AIKI)
Historical Stock Chart
From Mar 2024 to Apr 2024
Alkido Pharma (NASDAQ:AIKI)
Historical Stock Chart
From Apr 2023 to Apr 2024